A Brief Overview of This Month’s JACI Volume 135, Number 2, February 2015 REVIEWS AND FEATURE ARTICLES 395 D prostanoid receptor 2 (chemoattractant receptor–homologous molecule expressed 299 Asthma phenotypes and the use of biologic on T 2 cells) protein expression in asthmatic medications in asthma and allergic disease: H patients and its effects on bronchial epithelial The next steps toward personalized care cells Merritt L. Fajt et al Sally E. Stinson et al 312 The future of biologics: Applications 407 The Xolair Pregnancy Registry (EXPECT): The for food allergy safety of omalizumab use during pregnancy a N. Bauer et al Jennifer Namazy et al 324 The translational revolution and use 413 Subsets of airway myeloid-derived regulatory of biologics in patients with inflammatory cells distinguish mild asthma from chronic skin diseases obstructive pulmonary disease Shinji Noda et al Jessy S. Deshane et al 337 The potential pharmacologic mechanisms 425 DNA-dependent protein kinase inhibition of omalizumab in patients with chronic blocks asthma in mice and modulates spontaneous urticaria + human endothelial and CD4 T-cell function Tse Wen Chang et al without causing bined 343 Worms as therapeutic agents for allergy immunodeficiency and asthma: Understanding why benefits Mohamed A. Ghonim et al in animal studies have not transl
Brief Overview of This Month's JACI[001].pdf 来自淘豆网www.taodocs.com转载请标明出处.